Premium
Clarithromycin as an adjunct to periodontal therapy: a systematic review and meta‐analysis
Author(s) -
Bashir Nasir Zeeshan,
Sharma Praveen
Publication year - 2022
Publication title -
international journal of dental hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.674
H-Index - 38
eISSN - 1601-5037
pISSN - 1601-5029
DOI - 10.1111/idh.12498
Subject(s) - medicine , meta analysis , clarithromycin , adverse effect , confidence interval , web of science , relative risk , mean difference , dentistry , helicobacter pylori
Objective To collate the literature evaluating the efficacy of clarithromycin as an adjunct to non‐surgical periodontal therapy and conduct meta‐analyses for changes in probing pocket depth (PPD) and clinical attachment level (CAL). Methods Five electronic databases were searched from inception to May 2020 (PubMed, Cochrane CENTRAL, EMBASE via OVID, Web of Science and OpenGrey). Clinical outcomes were extracted, pooled and meta‐analyses conducted using mean difference with standard deviations. Results Systemic delivery : 0.65 mm (95% CI: 0.02 to 1.27 mm) mean additional PPD reduction was observed at 3 months and 0.28 mm (95% CI: −0.32 to 0.87 mm) at 6 months. 0.41 mm (95% CI: −0.12 to 0.95 mm) mean additional CAL gain was observed at 3 months, and 0.16 mm (95% CI: −0.41 to 0.74 mm) at 6 months. Increased risk of adverse events was observed; RR: 5.13 (95% CI: 0.63 to 41.98). Local delivery : 1.01 mm (95% CI: 0.84 to 1.17 mm) mean additional PPD reduction was observed at 3 months, and 1.20 mm (95% CI: 0.76 to 1.64 mm) at 6 months. 0.56 mm (95% CI: 0.46 to 0.66 mm) mean additional CAL gain was observed at 3 months, and 0.83 mm (95% CI: 0.65 to 1.02 mm) at 6 months. No adverse events were observed. Conclusions The use of locally delivered clarithromycin significantly improves treatment outcomes.